SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031929
Filing Date
2021-12-20
Accepted
2021-12-17 18:26:17
Documents
12
Period of Report
2021-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36694
  Complete submission text file 0001493152-21-031929.txt   208751

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ogen-20211216.xsd EX-101.SCH 3028
3 XBRL LABEL FILE ogen-20211216_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ogen-20211216_pre.xml EX-101.PRE 22361
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3665
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 211503060
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences